Katsuhara, Yukari
Ikeda, Shunya
Article History
Accepted: 23 January 2021
First Online: 10 February 2021
Declarations
:
: The authors received no specific funding for this study.
: Yukari Katsuhara is an employee of Takeda Pharmaceutical Company Limited and had been on leave during the research period. Shunya Ikeda has no conflict of interest.
: This study used anonymized information from the database, which is open to the public; therefore, in accordance with the 1964 Helsinki Declaration (and its amendments), institutional ethics approval was not required.
: This study used anonymized information from the database, which is open to the public; therefore, in accordance with the 1964 Helsinki Declaration (and its amendments), institutional ethics approval was not required.
: Not applicable.
: The datasets analyzed in this study are available in the FDA Adverse Event Reporting System (FAERS): ExternalRef removed
: Not applicable.
: Both authors were investigators in the study and participated in the study design, interpretation of the study results, and in the drafting, critical revision, and approval of the final version of the manuscript.
: Not applicable.